Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Corbin

Showing results (31-40 of 128) with videos related to

Pageof 13
Sort By:
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|June 18, 2025
Financial Toxicity of Partial Versus Whole Breast Irradiation: A Systematic ReviewTaema Brinjikji, Kimberly S Corbin, Zhen Wang, et al.
Hematology/Oncology Clinics of North America|January 18, 2025
Patient, Caregiver, and Provider Well-Being in OncologyKimberly R Gergelis, Alissa Huston, Ciara C O'Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2011
Feasibility and acute toxicity of hypofractionated radiation in large-breasted patientsPaige L Dorn, Kimberly S Corbin, Hania Al-Hallaq, et al.
Journal of the American Chemical Society|October 25, 2001
Complexation-induced unfolding of heterocyclic ureas. Simple foldamers equilibrate with multiply hydrogen-bonded sheetlike structuresP S Corbin, S C Zimmerman, P A Thiessen, et al.
Brachytherapy|November 14, 2020
EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for <sup>125</sup>I Collaborative Ocular Melanoma Study eye plaquesChristopher L Deufel, Sarah McCauley Cutsinger, Kimberly S Corbin, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 20, 2010
A multicenter investigation of OPTI-FREE RepleniSH multi-purpose disinfecting solution impact on soft contact lens patient comfortGlenn S Corbin, Linda Bennett, Louis Espejo, et al.
The Journal of Clinical Investigation|December 16, 2010
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activityAmie S Corbin, Anupriya Agarwal, Marc Loriaux, et al.
Cancer Research|December 25, 2002
Activity of the Bcr-Abl kinase inhibitor PD180970 against clinically relevant Bcr-Abl isoforms that cause resistance to imatinib mesylate (Gleevec, STI571)Paul La Rosée, Amie S Corbin, Eric P Stoffregen, et al.
Blood|February 11, 2003
Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinibAmie S Corbin, Paul La Rosée, Eric P Stoffregen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2002
Discrete and polymeric self-assembled dendrimers: hydrogen bond-mediated assembly with high stability and high fidelityPerry S Corbin, Laurence J Lawless, Zhanting Li, et al.
Pageof 13

Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|June 18, 2025
Financial Toxicity of Partial Versus Whole Breast Irradiation: A Systematic ReviewTaema Brinjikji, Kimberly S Corbin, Zhen Wang, et al.
Hematology/Oncology Clinics of North America|January 18, 2025
Patient, Caregiver, and Provider Well-Being in OncologyKimberly R Gergelis, Alissa Huston, Ciara C O'Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2011
Feasibility and acute toxicity of hypofractionated radiation in large-breasted patientsPaige L Dorn, Kimberly S Corbin, Hania Al-Hallaq, et al.
Journal of the American Chemical Society|October 25, 2001
Complexation-induced unfolding of heterocyclic ureas. Simple foldamers equilibrate with multiply hydrogen-bonded sheetlike structuresP S Corbin, S C Zimmerman, P A Thiessen, et al.
Brachytherapy|November 14, 2020
EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for <sup>125</sup>I Collaborative Ocular Melanoma Study eye plaquesChristopher L Deufel, Sarah McCauley Cutsinger, Kimberly S Corbin, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 20, 2010
A multicenter investigation of OPTI-FREE RepleniSH multi-purpose disinfecting solution impact on soft contact lens patient comfortGlenn S Corbin, Linda Bennett, Louis Espejo, et al.
The Journal of Clinical Investigation|December 16, 2010
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activityAmie S Corbin, Anupriya Agarwal, Marc Loriaux, et al.
Cancer Research|December 25, 2002
Activity of the Bcr-Abl kinase inhibitor PD180970 against clinically relevant Bcr-Abl isoforms that cause resistance to imatinib mesylate (Gleevec, STI571)Paul La Rosée, Amie S Corbin, Eric P Stoffregen, et al.
Blood|February 11, 2003
Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinibAmie S Corbin, Paul La Rosée, Eric P Stoffregen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2002
Discrete and polymeric self-assembled dendrimers: hydrogen bond-mediated assembly with high stability and high fidelityPerry S Corbin, Laurence J Lawless, Zhanting Li, et al.
Pageof 13